Efficacy News and Research

RSS
PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Clinical trial of Grafix for treatment of chronic diabetic foot ulcers accepted for presentation at SAWC

Clinical trial of Grafix for treatment of chronic diabetic foot ulcers accepted for presentation at SAWC

Tactile Medical launches ambulatory device to heal venous leg ulcers

Tactile Medical launches ambulatory device to heal venous leg ulcers

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Prophylactic cranial irradiation beneficial in elderly SCLC patients

Prophylactic cranial irradiation beneficial in elderly SCLC patients

Cellular Biomedicine Group reports interim results of Phase I/IIa clinical trial for Knee Osteoarthritis

Cellular Biomedicine Group reports interim results of Phase I/IIa clinical trial for Knee Osteoarthritis

Scientists develop robotic systems for image-guided removal of hard-to-reach brain tumors

Scientists develop robotic systems for image-guided removal of hard-to-reach brain tumors

Chemotherapy best second-line option for EGFR wild-type NSCLC

Chemotherapy best second-line option for EGFR wild-type NSCLC

Pivotal Study Supports Use of IMNOVID®▼ Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Pivotal Study Supports Use of IMNOVID®▼ Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Experimental agent fails to increase HDL levels, reveals new study

Experimental agent fails to increase HDL levels, reveals new study

Hokusai-VTE findings provide fresh insight into patients with pulmonary embolism

Hokusai-VTE findings provide fresh insight into patients with pulmonary embolism

Rigel plans to focus on completing three clinical programs for ITP, DLE and dry eye disease

Rigel plans to focus on completing three clinical programs for ITP, DLE and dry eye disease

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Increased mortality in schizophrenia ‘not attributable to drug therapy’

Increased mortality in schizophrenia ‘not attributable to drug therapy’

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Radiologists train military physicians to remove foreign bodies with ultrasound-guided techniques

Radiologists train military physicians to remove foreign bodies with ultrasound-guided techniques

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Aliskiren does not slow progression of coronary atherosclerosis in prehypertension patients

Aliskiren does not slow progression of coronary atherosclerosis in prehypertension patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.